. More than two fifths of the world's population (2.5 billion) lives in areas potentially at risk for dengue 3 . Dengue is considered to be one of the most important infectious diseases in these regions 4 .
DF is a severe, flu-like illness that affects infants, young children and adults, but seldom causes death 2 . The first documented outbreak of DF in Bangladesh was in 1965 when it was called "Dhaka fever" 5 . The 1 st sero-epidemiological study of Bangladesh to detect dengue infection was done at Chittagong Medical College hospital (CMCH), Chittagong in 1996 through 1997, and was found that 13.75% cases of fever were seropositive for dengue infection 6 . In Bangladesh, an outbreak of DF and DHF occurred in and around Dhaka city during the summer of 1999 7 .Since then dengue cases are reported every year in different media and series [6] [7] [8] [9] .
The clinical features of dengue vary with the age of the patient and, in addition to clinically inapparent J MEDICINE 2006; 7: 3-9 
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infections, can be classified into five presentations: non-specific febrile illness, classic dengue (DF), dengue haemorrhagic fever (DHF), dengue haemorrhagic fever with dengue shock syndrome (DSS), and other unusual syndromes such as encephalopathy and fulminant liver failure 10, 11 .
Young children with dengue often have an undifferentiated febrile illness with a maculopapular rash. Upper respiratory infections, especially pharyngitis, are common. Most infections in children under 15 years are asymptomatic or minimally symptomatic; a study of school children in Thailand found only 13% of those infected missed more than one day of school because of illness 12 . Classic dengue is more commonly seen among older children, adolescents, and adults. They are less likely to be asymptomatic. Dengue is abrupt in onset, typically with high fever accompanied by severe headache, incapacitating myalgia and arthralgia, nausea and vomiting, and rash. Rash, typically macular or maculopapular, often becoming confluent and sparing small islands of normal skin, has been reported in over half of infected people. Other signs and symptoms include flushed facies, sore throat, cough, cutaneous hyperaesthesia, and taste aberrations. Recovery may be prolonged and include depression 13 .
The hallmark of dengue hemorrhagic fever is capillary leakage, accompanied by hemorrhagic manifestations. The presentation of patients in the first days of the illness is similar to that seen in dengue fever, but plasma leakage develops four to seven days after the onset of the disease, at approximately the time of deffervescence. Abdominal pain and vomiting, restlessness, a change in the level of consciousness, and a sudden change from fever to hypothermia may be the first clinical warning signs and are often associated with a marked decrease in the platelet count 13 .
The diagnosis of dengue hemorrhagic fever is made on the basis of the following triad of symptoms and signs: hemorrhagic manifestations; a platelet count of less than 100,000 per cubic millimeter; and objective evidence of plasma leakage, shown either by fluctuation of packed-cell volume (>20% during the course of the illness) or by clinical signs of plasma leakage, such as pleural effusion, ascites, or hypoproteinemia. Hemorrhagic manifestations without capillary leakage do not constitute dengue hemorrhagic fever. A positive tourniquet test is incorporated in the WHO clinical case definition of dengue hemorrhagic fever, but the definition differentiates poorly between dengue and dengue hemorrhagic fever and is not very specific 14 . Mortality rates from dengue hemorrhagic fever can range as high as 10 to 20 percent, but they are as low as 0.2 percent in hospitals with staff experienced in the management of the disease 2, 13, 15 .
Dengue shock syndrome is characterized by a rapid, weak pulse with a narrowing pulse pressure of less than 20 mm Hg, or profound hypotension (systolic pressure of less than 90 mm Hg among those five years of age or older). The duration of shock is short. Typically, patients either recover rapidly after appropriate volume-replacement therapy is administered or die within 12 to 24 hours; the mortality rate is up to 40 percent 13, 15 .
In most of the cases the disease can be managed well according to the guideline provided by WHO 16 . In this guideline severity of dengue is stratified on the basis of fluid leakage and bleeding.
Materials and Method:
The study was carried out at DMCH from July 2000 to March 2001. A total of 150 dengue patients were recruited who were diagnosed on the basis of WHO criteria and confirmed by the presence of antidengue IgM and IgG antibody. Study subjects are classified into 03 (three) groups depending on the clinical and laboratory findings. Subjects are selected according to the selection criteria and excluded following the exclusion criteria. Statistical analysis were done using SPSS to see correlation between clinical manifestations and severity of dengue infection.
Selection criteria:
Group-1(DF):
Subjects with acute febrile illness for not more than 2-7 days having the manifestations like 
Group-2 (DHF):
Group 1 manifestations plus hemorrhagic manifestation evidenced by one or more of the followings.
1. Positive tourniquet test.
2. Petechiae, ecchymosis, purpura 3. Bleeding from different sites like epistaxis, gum bleeding, haematemesis, melaena, haematuria, menorrhagia and 4. Any evidence of plasma leakage manifested by
• A 20% rise in PCV for the age or sex and / or
• A 20% drop in PCV following treatment with intravenous fluid and/ or
• Pleural effusion, ascites, hypoproteinemia.
Group -3(DSS):
Subjects with DHF manifesting circulatory failure as follows 1. Hypotension for age and/ or 2. Narrow pulse pressure (<20 mmHg) and/ or 3. Profound shock.
Exclusion criteria

Pregnancy 2. Patients with other co morbid conditions
Results
A total 150 clinically and serologically diagnosed dengue infection were classified into three groups, i.e. 18 (12%) cases of dengue fever (group 1), 127 (84.67%) cases of dengue hemorrhagic fever/ DHF (group 2), and 5(3.33%) cases of dengue shock syndrome/ DSS (group 3). The majority of the study subjects were male and male to female ratio was 5:1( Headache and myalgia were the common clinical presentations .100% of group-3 patients had complained of headache, myalgia, low-back pain, retro-orbital pain and arthralgia. Retro-orbital pain was present only in 33% group-1 and 33.9 % group-2 subjects. Low backache was recorded in 44.4% of group-1 and 53.5% of group-3 subjects (table -4) . Anorexia, nausea, and vomiting were common in all groups. Diarrhea and abdominal pain were present in 100% cases in group-3, whereas infrequent complains in other groups (table-5). Different types of rash i.e. macular, maculopapular and erythematous rashes over the trunk were observed. 67% of group-1 and 60% of group-2 and group-3 subjects had no rash. Melaena (OBT +ve) was the common hemorrhagic manifestation (66.3% in group-2 & 100% in group-3) followed by gum bleeding (37% in group-2 & 100% in group-3). Majority of the patients of group-2 (68.5%) and group-3 (100%) had more than one bleeding manifestations. Tourniquet test was positive in 16.7% of group-1, 74.8% of group-2 and 80% of group-3 subjects (table-6).
Organomegaly was observed very rarely except in group-3 (60% had hepatomegaly and 40% had spleenomegaly). Majority of the group-3 also had ascites (80%) and 40% had pleural effusion (table-7) . Only three (two of group-2 & one in group-3) patients had jaundice, none had hepatic encephalopathy.
Discussion:
In this study, we primarily focused on the clinical manifestations and their associations with the severity of 150 clinically and serologically proved dengue patients. DSS patients were significantly (p<0.05) younger. Mean age of the subjects were 26.75 ±3.69, 27.59 ± 1.18 and 10.67 ± 2.33 years respectively of group-1, group-2 and group respectively. Chareonsook O et al 17 showed that adults are now also being affected with DHF/DSS. Wali JP et al 18 showed that mean age was 31±5.2 (SD), with most of the patients were in the range of 20-50 years, which is almost similar to this study.
Majority of the patients experienced high-grade fever.
Only a small number of subjects (22.2%, 30.7% and 60% in respective 3 groups) experienced chills and rigor, but Anuradha S et al 19 showed that fever was of high grade with chills and rigors. Mean duration of fever (5.50±0.51 days in G-1, 6.12±0.2 days in G-2, and 5.00±1.15 in G-3 subjects) in our study was similar to that of Anuradha S et al (4.8±1.32 days), but differ to that of Wali JP et al 18 (4±1.12 days).
Anuradha S et al 19 reported 96% of her study subjects suffered myalgia and other aches while Wali JP et al 18 showed headache in 80.9%, myalgia 76.2%, arthralgia 52.3% and these were the common symptoms which are similar to the findings in this study. Richards AL et al reported headache in 96.7%, backache in 39.1%, and retro-orbital pain in 13.1% of all his 72 study subjects, which are closely related to the present study. Respiratory symptoms are infrequent findings in our study. None of them experienced dyspnoea. Only a small number of groug-1 and group-2 subjects complained of cough (18.1%), chest pain (24%), and prostration.
Anorexia, nausea, and vomiting were common complains of all study subjects. Diarrhea and abdominal pain were common complains in groupm 3 patients, whereas infrequent complains in other groups, which was very similar to Wali JP et al 18 study. Organomegaly was infrequent finding, except in group-3 patients. Ascites (80%) and pleural effusion (40%) was also common in group-3 patients. Kabra SK et al 20 found ascites in 87%, pleural effusin in 74% in DSS patients, whereas only 27% DHF without DSS had ascites and pleural effusion. Sai PMV et al 21 on his sonographic study on fifth to seventh day of fever showed that all had gall bladder wall thickening, 21% had hepatomegaly, 7% had splenomegaly, 96% had ascites, 87.5% had right pleural effusion, 66% had left pleural effusion and 28.5% had pericardial fluid and concluded, in an epidemic of dengue, ultrasound features of thickened gall bladder wall, pleural effusion and ascites should strongly favored the diagnosis of dengue fever. Jaundice was found only in 2% of patients, which was less than that of Kabra SK et al 20 .
Different pattern of rash over the trunk e.g. macular 12%, maculopapular 10%, and erythematous 10% (total >37%) were observed. Tourniquet test was positive in 16.7%, 74.8%, and 80% patients of consecutive three groups. Phuong CXT et al 14 showed that 712 dengue-infected children had considerable overlap in the major clinical features. Mucosal bleeding was observed with equal frequency in those with dengue fever and dengue hemorrhagic fever (DHF), and petechiae, thrombocytopenia, and the tourniquet test differentiated poorly between the two diagnostic categories. Kabra SK et al 20 reported tourniquet test positive in 40% of classical dengue, 62% of DHF, and 64% 0f DSS patients. Melaena was the commonest haemorrhagic manifestations (group2 -65.3% and group3-100%) followed by gum bleeding manifestations (group2 -37% and group3-100%). More than one variety of haemorrhagic manifestations was observed in most patients (group2 -68.5% and group3-100%), which was very similar to the findings of Wali JP et al 18 and Anuradha S et al 19 . Haemorrhagic manifestations were common one day after subsidence of fever.
Conclusion:
During the initial outbreak, the nature of the disease, non-acquaintance of the professionals and unfamiliarity on the part of the general people has made the situation a panic. Patients with dengue syndrome showed varied presentation and the symptoms are non specific. So it necessitates clinical awareness to combat mortality and morbidity. In this study, we tried to find out the clinical parameters with varied presentations to create better awareness and clinically diagnostic skills among the health care providers and people to identify and refer the patients promptly to proper health care facilities to avert the ultimate danger.
